Jump to content

Pharmstandard: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
Addbot (talk | contribs)
Bots
2,838,809 edits
m Bot: Migrating 2 interwiki links, now provided by Wikidata on d:q4391720
Adding short description: "Russian pharmaceutical company"
 
(41 intermediate revisions by 24 users not shown)
Line 1: Line 1:
{{Short description|Russian pharmaceutical company}}
{{Use dmy dates|date=May 2011}}
{{Use dmy dates|date=October 2020}}
{{Infobox company |
{{Infobox company
company_name = JSC Pharmstandard|
| name = JSC Pharmstandard|
company_type = [[Public company|Public]] |
| type = [[Privately held company|Private]]
traded_as = {{MICEX-RTS|PHST}}<br>{{lse|PHST}}|
| traded_as =
company_logo = [[File:Pharmstandard.gif|120px]]|
| logo = Pharmstandard.svg
company_slogan = |
foundation = 2003 |
| foundation = 2003
location = [[Ufa]], Russia |
| location = [[Dolgoprudny]], [[Russia]]
area_served = |
| area_served = Worldwide
key_people = Viktor Vladimirovich Kharitonin,([[Chairman]]) <BR> Igor Konstantinovich Krylov, ([[CEO]])|
| key_people = [[Viktor Kharitonin]] <small>([[Chairman]])</small> <BR> Igor Krylov <small>([[CEO]])</small>
industry = [[Pharmaceuticals]] |
| industry = [[Pharmaceuticals]]
products = Remedies |
| products = Remedies
revenue = {{increase}} [[US$]] 1.0 Billion (2010) |
| revenue = {{wikidata revenue|revenue|USD}}{{wikidata revenue|revenue|ref}}
| revenue_year = {{wikidata revenue|revenue|year}}
operating_income = |
| operating_income = {{wikidata revenue|operating_income|USD}}{{wikidata revenue|operating_income|ref}}
net_income = {{profit}} [[US$]] 255.5 Million (2010) |
| income_year = {{wikidata revenue|operating_income|year}}
num_employees = 5,001|
| net_income = {{wikidata revenue|net_income|USD}}{{wikidata revenue|net_income|ref}}
⚫
homepage = [http://www.pharmstd.ru www.pharmstd.ru] |
| net_income_year = {{wikidata revenue|net_income|year}}
intl = yes |
| assets = {{wikidata revenue|assets|USD}}{{wikidata revenue|assets|ref}}
| assets_year = {{wikidata revenue|assets|year}}
| equity = {{wikidata revenue|equity|USD}}{{wikidata revenue|equity|ref}}
| equity_year = {{wikidata revenue|equity|year}}
| num_employees = {{Wikidata employees}}{{Wikidata employees|ref}}
| num_employees_year = {{Wikidata employees|year}}
⚫
| homepage = [http://pharmstd.com/ pharmstd.com]
}}
}}
'''JSC Pharmstandard''' ({{lang-ru|ПАО "Фармстандарт"|PAO "Farmstandart"}}) is a Russian multinational<ref>[http://www.pharmstd.lu Pharmstandard International]</ref> pharmaceutical company.<ref name="zhuplev14"/> It is headquartered in [[Dolgoprudny]], [[Moscow Oblast]].


⚫
Pharmstandard's makes and exports over 400 generic and proprietary drugs, including products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc.{{citation needed|date=September 2020}}
'''Pharmstandard''' is the leading Russian pharmaceutical company, its headquartered in [[Ufa]].

⚫
Pharmstandard portfolio includes over 200 products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc. Over 90 products offered by Pharmstandard are included in the List of Vital Pharmaceutical Products.


The company has six manufacturing facilities located in Moscow, [[Ufa]], [[Nizhny Novgorod]], [[Kursk]], [[Tomsk]] and [[Tyumen]].
The company has six manufacturing facilities located in Moscow, [[Ufa]], [[Nizhny Novgorod]], [[Kursk]], [[Tomsk]] and [[Tyumen]].


== References ==
==History==
Pharmstandard was established in 2003 as a result of a merger.<ref name="zhuplev14">{{cite book|last1=Anatoly|first1=Zhuplev|title=Geo-Regional Competitiveness in Central and Eastern Europe, the Baltic Countries, and Russia|date=2014|publisher=IGI Global|isbn=9781466660557|page=228|url=https://books.google.com/books?id=8BOXBQAAQBAJ&pg=PA228}}</ref>


In May 2007 the company raised $880 million in an [[Initial public offering|IPO]], valuing the company at $2.2 billion.<ref>{{cite news|last1=Spikes|first1=Salamander Davoudiand Sarah|title=Russian drug IPO raises $880m|url=http://www.ft.com/cms/s/0/dab0b26a-faa7-11db-8bd0-000b5df10621.html?ft_site=falcon&desktop=true|accessdate=25 September 2017|work=Financial Times|date=5 May 2007}}</ref> [[Roman Abramovich]] owned a 17% stake in the company until March 2008.<ref name="uful">{{cite news|title=Russia's Abramovich sells his stake in drug maker|url=https://www.reuters.com/article/abramovich-pharmstandard/russias-abramovich-sells-his-stake-in-drug-maker-idUSL2750878720080327|accessdate=25 September 2017|work=Reuters|date=2008}}</ref>
{{RTSI}}

{{Moscow Exchange companies}}
In 2013 the company announced plans to buy the ingredient supplier Bever Pharmaceutical, causing Pharmstandard shares to fall 25%.<ref>{{cite news|title=Pharmstandard to buy ingredient supplier for $590 million|url=https://www.reuters.com/article/us-russia-pharmstandard-deal/pharmstandard-to-buy-ingredient-supplier-for-590-million-idUSBRE97C0D020130813|accessdate=25 September 2017|work=Reuters|date=2013}}</ref>

Pharmstandard was delisted from the London and Moscow stock exchanges in 2017.<ref>{{cite news|title=BRIEF-Pharmstandard shares to be delisted as of March 24 - Moscow Exchange|url=https://www.reuters.com/article/brief-pharmstandard-shares-to-be-deliste-idUSFWN1G20GB|accessdate=23 April 2017|work=Reuters|date=17 February 2017}}</ref><ref>{{cite web|title=Об исключении ценных бумаг из Списка ценных бумаг, допущенных к торгам, и о прекращении торгов ценными бумагами|url=http://www.moex.com/n15172|website=Московская Биржа|accessdate=28 August 2017}}</ref>

== References ==
{{reflist}}


[[Category:Companies listed on the Moscow Exchange]]
[[Category:Pharmaceutical companies of Russia]]
[[Category:Russian brands]]
[[Category:Pharmaceutical companies established in 2003]]
[[Category:2003 establishments in Russia]]
[[Category:Multinational companies headquartered in Russia]]
[[Category:Companies based in Moscow Oblast]]
[[Category:Companies formerly listed on the Moscow Exchange]]

Latest revision as of 01:46, 22 December 2023

JSC Pharmstandard
Company typePrivate
IndustryPharmaceuticals
Founded2003
HeadquartersDolgoprudny, Russia
Area served
Worldwide
Key people
Viktor Kharitonin (Chairman)
Igor Krylov (CEO)
ProductsRemedies
Revenue$638 million[1] (2017)
$231 million[2] (2016)
$119 million[2] (2016)
Total assets$1.41 billion[2] (2016)
Total equity$936 million[2] (2016)
Number of employees
6,450[3] (2015)
Websitepharmstd.com

JSC Pharmstandard (Russian: ПАО "Фармстандарт", romanized: PAO "Farmstandart") is a Russian multinational[4] pharmaceutical company.[5] It is headquartered in Dolgoprudny, Moscow Oblast.

Pharmstandard's makes and exports over 400 generic and proprietary drugs, including products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc.[citation needed]

The company has six manufacturing facilities located in Moscow, Ufa, Nizhny Novgorod, Kursk, Tomsk and Tyumen.

History

[edit]

Pharmstandard was established in 2003 as a result of a merger.[5]

In May 2007 the company raised $880 million in an IPO, valuing the company at $2.2 billion.[6] Roman Abramovich owned a 17% stake in the company until March 2008.[7]

In 2013 the company announced plans to buy the ingredient supplier Bever Pharmaceutical, causing Pharmstandard shares to fall 25%.[8]

Pharmstandard was delisted from the London and Moscow stock exchanges in 2017.[9][10]

References

[edit]
  1. ^ "Рейтинг крупнейших компаний России по объему реализации продукции". Expert RA. Archived from the original on 28 October 2018. Retrieved 28 October 2018.
  2. ^ a b c d http://pharmstd.com/news3files/2016ifrsresults.pdf. {{cite web}}: Missing or empty |title= (help)
  3. ^ http://www.rbc.ru/companies/id/126. {{cite web}}: Missing or empty |title= (help)
  4. ^ Pharmstandard International
  5. ^ a b Anatoly, Zhuplev (2014). Geo-Regional Competitiveness in Central and Eastern Europe, the Baltic Countries, and Russia. IGI Global. p. 228. ISBN 9781466660557.
  6. ^ Spikes, Salamander Davoudiand Sarah (5 May 2007). "Russian drug IPO raises $880m". Financial Times. Retrieved 25 September 2017.
  7. ^ "Russia's Abramovich sells his stake in drug maker". Reuters. 2008. Retrieved 25 September 2017.
  8. ^ "Pharmstandard to buy ingredient supplier for $590 million". Reuters. 2013. Retrieved 25 September 2017.
  9. ^ "BRIEF-Pharmstandard shares to be delisted as of March 24 - Moscow Exchange". Reuters. 17 February 2017. Retrieved 23 April 2017.
  10. ^ "Об исключении ценных бумаг из Списка ценных бумаг, допущенных к торгам, и о прекращении торгов ценными бумагами". Московская Биржа. Retrieved 28 August 2017.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pharmstandard&oldid=1191188581"